Literature DB >> 27552964

Chromosomal abnormalities in hepatic cysts point to novel polycystic liver disease genes.

Edgar S Wills1,2, Wybrich R Cnossen1,2, Joris A Veltman2,3, Rob Woestenenk4, Marloes Steehouwer2, Jody Salomon1, René H M Te Morsche1, Meritxell Huch5,6,7, Jayne Y Hehir-Kwa2, Martijn J Banning2, Rolph Pfundt2, Ronald Roepman2,8, Alexander Hoischen2,8, Joost P H Drenth1,8.   

Abstract

Autosomal dominant polycystic liver disease (ADPLD) is caused by variants in PRKCSH, SEC63, and LRP5, whereas autosomal dominant polycystic kidney disease is caused by variants in PKD1 and PKD2. Liver cyst development in these disorders is explained by somatic loss-of-heterozygosity (LOH) of the wild-type allele in the developing cyst. We hypothesize that we can use this mechanism to identify novel disease genes that reside in LOH regions. In this study, we aim to map abnormal genomic regions using high-density SNP microarrays to find novel PLD genes. We collected 46 cysts from 23 patients with polycystic or sporadic hepatic cysts, and analyzed DNA from those cysts using high-resolution microarray (n=24) or Sanger sequencing (n=22). We here focused on regions of homozygosity on the autosomes (>3.0 Mb) and large CNVs (>1.0 Mb). We found frequent LOH in PRKCSH (22/29) and PKD1/PKD2 (2/3) cysts of patients with known heterozygous germline variants in the respective genes. In the total cohort, 12/23 patients harbored abnormalities outside of familiar areas. In individual ADPLD cases, we identified germline events: a 2q13 complex rearrangement resulting in BUB1 haploinsufficiency, a 47XXX karyotype, chromosome 9q copy-number loss, and LOH on chromosome 3p. The latter region was overlapping with an LOH region identified in two other cysts. Unique germline and somatic abnormalities occur frequently in and outside of known genes underlying cysts. Each liver cyst has a unique genetic makeup. LOH driver gene BUB1 may imply germline causes of genetic instability in PLD.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27552964      PMCID: PMC5117941          DOI: 10.1038/ejhg.2016.97

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  45 in total

1.  Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma.

Authors:  H Bläker; W J Hofmann; R J Rieker; R Penzel; M Graf; H F Otto
Journal:  Genes Chromosomes Cancer       Date:  1999-08       Impact factor: 5.006

2.  Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease.

Authors:  Esmé Waanders; René H M te Morsche; Rob A de Man; Jan B M J Jansen; Joost P H Drenth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

3.  Tumor susceptibility of Rassf1a knockout mice.

Authors:  Stella Tommasi; Reinhard Dammann; Zhongqiu Zhang; Yian Wang; Limin Liu; Walter M Tsark; Sharon P Wilczynski; Jie Li; Ming You; Gerd P Pfeifer
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

Review 4.  Cystic disease in women: clinical characteristics and medical management.

Authors:  Arlene B Chapman
Journal:  Adv Ren Replace Ther       Date:  2003-01

5.  Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity.

Authors:  Darren J Baker; Fang Jin; Karthik B Jeganathan; Jan M van Deursen
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

6.  Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate.

Authors:  Thomas Decaens; Cécile Godard; Aurélien de Reyniès; David S Rickman; François Tronche; Jean-Pierre Couty; Christine Perret; Sabine Colnot
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 7.  Polycystin-1: a master regulator of intersecting cystic pathways.

Authors:  Sorin V Fedeles; Anna-Rachel Gallagher; Stefan Somlo
Journal:  Trends Mol Med       Date:  2014-01-31       Impact factor: 11.951

8.  Unified criteria for ultrasonographic diagnosis of ADPKD.

Authors:  York Pei; James Obaji; Annie Dupuis; Andrew D Paterson; Riccardo Magistroni; Elizabeth Dicks; Patrick Parfrey; Benvon Cramer; Eliecer Coto; Roser Torra; Jose L San Millan; Robert Gibson; Martijn Breuning; Dorien Peters; David Ravine
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

9.  Genomic instability in patients with autosomal-dominant polycystic kidney disease.

Authors:  Ming Li; Songbing Qin; Lili Wang; Juying Zhou
Journal:  J Int Med Res       Date:  2013-01-24       Impact factor: 1.671

10.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Authors:  Anna Caroli; Norberto Perico; Annalisa Perna; Luca Antiga; Paolo Brambilla; Antonio Pisani; Bianca Visciano; Massimo Imbriaco; Piergiorgio Messa; Roberta Cerutti; Mauro Dugo; Luca Cancian; Erasmo Buongiorno; Antonio De Pascalis; Flavio Gaspari; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2013-08-21       Impact factor: 79.321

View more
  6 in total

1.  An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease.

Authors:  Murali K Yanda; Qiangni Liu; Liudmila Cebotaru
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-26

Review 2.  Genetics, pathobiology and therapeutic opportunities of polycystic liver disease.

Authors:  Paula Olaizola; Pedro M Rodrigues; Francisco J Caballero-Camino; Laura Izquierdo-Sanchez; Patricia Aspichueta; Luis Bujanda; Nicholas F Larusso; Joost P H Drenth; Maria J Perugorria; Jesus M Banales
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-05-13       Impact factor: 73.082

Review 3.  Molecular Mechanisms of Isolated Polycystic Liver Diseases.

Authors:  Ziqi Yu; Xiang Shen; Chong Hu; Jun Zeng; Aiyao Wang; Jianyong Chen
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

4.  Long-term outcome of incidental cystic liver tumors in the general population.

Authors:  S F U Blum; T Ittermann; M L Kromrey; C M Dreyer; D Seppelt; R T Hoffmann; H Völzke; J P Kühn
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

5.  Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis.

Authors:  Qi-Feng Chen; Jin-Guo Xia; Wang Li; Lu-Jun Shen; Tao Huang; Peihong Wu
Journal:  Mol Med Rep       Date:  2018-09-19       Impact factor: 2.952

Review 6.  Disease modelling in human organoids.

Authors:  Madeline A Lancaster; Meritxell Huch
Journal:  Dis Model Mech       Date:  2019-07-29       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.